Delivery Order SPE2DB20D1102-SPE2DB24FC6UW

Award Date 8/21/24
Potential Completion Date 9/12/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,974.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order and has a firm fixed-price pricing type, with a final completion date of February 27, 2025. The award is not designated under any set-aside program. It provides for the delivery of HYPERTET 250 UNIT/ML SYRINGE medical supplies, which are likely used for the...
This federal contract award, valued at $1,662.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of HYPERTET 250 UNIT/ML SYRINGEML, a medical product. The award has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,134 Firm Fixed Price Delivery Order is for the supply of 4565350217 – HYPERTET 250 UNIT/ML SYRINGEML, a medical product. The contract has an ultimate completion date of August 26, 2024 and was awarded on August 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HYPERTET 250 UNIT/ML SYRINGEML medical devices. The $1,761.90 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.92 firm fixed-price delivery order contract is for the supply of HYPERTET 250 UNIT/ML SYRINGEML, a specialty medical product. The contract has a period of performance through December 11, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award, valued at $1,512.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of HYPERTET 250 UNIT/ML SYRINGEML, a medical supply item, with a period of performance through January 3, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,409.52, is for the procurement of HYPERTET 250 UNIT/ML SYRINGEML, a medical product. The contract has an ultimate completion date of February 18, 2025 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
The federal contract award is for the delivery of HYPERTET 250 UNIT/ML SYRINGEML to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price of $1,438.05 and a completion date of July 8, 2022. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HYPERTET 250 UNIT/ML SYRINGEML, with a ceiling value of $1,150.44 and a performance period through December 5, 2022. The contract is a firm-fixed-price type and was not set aside for any specific business category. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas to support military...
  • SPE2DB20D1102
    Indefinite Delivery Contract
  • SPE2DB20D1102-SPE2DB24FC6UW
    Delivery Order

This federal contract award, valued at $1,662.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract is for the supply of 4565532857 - HYPERTET 250 UNIT/ML SYRINGEML, with an ultimate completion date of September 12, 2024. The contract utilizes a Firm Fixed Price pricing type. This award does not have a set-aside designation.

Generated 11/20/24, 9:22 AM